SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
(Amendment No. 5)
AVATEX CORPORATION
- ------------------------------------------------------------------------------
(Name of Issuer)
- ------------------------------------------------------------------------------
Common Stock
(Title of Class of Securities)
05349F105
- ------------------------------------------------------------------------------
(CUSIP Number)
- ------------------------------------------------------------------------------
Morris F. DeFeo, Jr.
Morrison & Foerster LLP
2000 Pennsylvania Avenue, N.W.
Washington, D.C. 20006
(202) 887-1682
- ------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
- ------------------------------------------------------------------------------
December 7, 1999
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1 (e), 13d-1(f) or 13d-1 (g), check the
following box. __
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
(Page 1 of 5 Pages)
<PAGE>
- ---------- --------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Phar-Mor, Inc.
251466309
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
3 SEC USE ONLY
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
|_|
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- ---------- --------------------------------------------------------------------
-------- --------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
4,948,600
SHARES
-------- --------------------------------------------------
-------- --------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
-0-
OWNED BY
-------- --------------------------------------------------
-------- --------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
4,948,600
REPORTING
-------- --------------------------------------------------
-------- --------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON
-0-
WITH
-------- --------------------------------------------------
- ---------- --------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,948,600
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
|-|
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
25.19%
- ---------- --------------------------------------------------------------------
- ---------- --------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- ---------- --------------------------------------------------------------------
This Amendment No. 5 ("Amendment No. 5") amends and/or supplements, as
indicated, Items 3, 5, 6 and 7 of the Schedule 13D filed by Phar-Mor, Inc., a
Pennsylvania corporation ("Phar-Mor"), with respect to the common stock, par
value $5.00 per share (the "Common Shares"), of Avatex Corporation, a Delaware
corporation (the "Issuer") on May 4, 1998 (the "Statement"), as amended by
Amendment No. 1 filed with the Securities and Exchange Commission (the
"Commission") on May 28, 1998 ("Amendment No. 1"), Amendment No. 2 filed with
the Commission on May 29, 1998 ("Amendment No. 2"), Amendment No. 3 filed with
the Commission on June 17, 1998 ("Amendment No. 3") and Amendment No. 4 filed
with the Commission on July 17, 1998 ("Amendment No. 4").
Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
Phar-Mor purchased a total of 2,961,400 Common Shares between July
17, 1998 and December 7, 1999 on the New York Stock Exchange, as
follows:
<TABLE>
<S> <C> <C>
Date Number of Shares Price per Common Share
- ---- ---------------- ----------------------
07/17/98 28,400 1.75
07/20/98 3,000 1.75
07/21/98 18,600 1.75
07/22/98 7,600 1.75
07/23/98 200 1.75
07/24/98 600 1.75
07/27/98 16,600 1.75
07/28/98 300 1.625
07/29/98 100 1.625
07/30/98 2,300 1.625
08/04/98 21,300 1.625
12/07/99 2,862,400 2.00
Total: 2,961,400
</TABLE>
All of the funds used to purchase the above-stated 2,961,400 Common Shares were
from Phar-Mor's general corporate funds.
<PAGE>
Item 5. INTEREST IN SECURITIES OF THE ISSUER
(a) The aggregate number of Common Shares beneficially owned by
Phar-Mor is 4,948,600 shares, constituting 25.19% of 19,647,000 Common Shares of
the Issuer issued and outstanding as of December 7, 1999.
(b) Phar-Mor has the sole power to vote, to direct the vote of,
and to dispose and to direct the disposition of 4,948,600 Common Shares of the
Issuer.
(c) Since the filing of Amendment No. 4, Phar-Mor purchased a
total of 2,961,400 Common Shares of the Issuer, as summarized in Item 3 above.
(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the proceeds from the sale of,
such securities.
(e) Not applicable.
Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
Phar-Mor does not have any contract, arrangement, understanding or
relationship (legal or otherwise) with any person with respect to any securities
of the Issuer, including but not limited to the transfer of any of the Common
Shares beneficially owned by Phar-Mor, finder's fees, joint ventures, loan or
option arrangements, puts or calls, guarantees of profits, division of profits
or loss, or the giving or withholding of proxies.
Item 7. MATERIAL TO BE FILED AS EXHIBITS
Not applicable.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: December 16, 1999
PHAR-MOR, INC.
By: /s/ John R. Ficarro
Name: John R. Ficarro
Title: Chief Administrative Officer
